These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 348119)

  • 41. Brunsting-Perry Type Pemphigoid Causing Secondary Cicatricial Alopecia in 2 Patients.
    Reis Gavazzoni Dias MF; Aparecida Guedes Vilar E; de Oliveira Bento C; Barreto Ibanez R; Falci Loures A; Barreto Oliveira Campos M; Monaco Santos J
    Skin Appendage Disord; 2018 Oct; 4(4):308-311. PubMed ID: 30410903
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Unusual subepidermal bullous diseases with immunologic features of bullous pemphigoid.
    Provost TT; Maize JC; Ahmed AR; Strauss JS; Dobson RL
    Arch Dermatol; 1979 Feb; 115(2):156-60. PubMed ID: 371547
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Cicatricial pemphigoid of Brunsting Perry].
    Iranzo P; Herrero C; Castro J; Castel T; Lecha M
    Actas Dermosifiliogr; 1979; 70(5-6):430-4. PubMed ID: 384761
    [No Abstract]   [Full Text] [Related]  

  • 44. Indirect complement immunofluorescence in the immunopathological assessment of bullous pemphigoid, cicatricial pemphigoid, and herpes gestationis.
    Hodge L; Black MM; Ramnarain N; Bhogal B
    Clin Exp Dermatol; 1978 Mar; 3(1):61-7. PubMed ID: 348362
    [No Abstract]   [Full Text] [Related]  

  • 45. Diagnostic value of indirect immunofluorescence on sodium chloride-split skin in differential diagnosis of subepidermal autoimmune bullous dermatoses.
    Ghohestani RF; Nicolas JF; Rousselle P; Claudy AL
    Arch Dermatol; 1997 Sep; 133(9):1102-7. PubMed ID: 9301587
    [TBL] [Abstract][Full Text] [Related]  

  • 46. U-serrated immunodeposition pattern differentiates type VII collagen targeting bullous diseases from other subepidermal bullous autoimmune diseases.
    Vodegel RM; Jonkman MF; Pas HH; de Jong MC
    Br J Dermatol; 2004 Jul; 151(1):112-8. PubMed ID: 15270879
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dermatitis herpetiformis and bullous pemphigoid. Intermediate and mixed forms.
    Jablonska S; Chorzelski TP; Beutner EH; Maciejowska E; Rzesa G
    Arch Dermatol; 1976 Jan; 112(1):45-8. PubMed ID: 1108803
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cicatricial pemphigoid: immunofluorescent findings.
    Hudson PM; Black MM
    Proc R Soc Med; 1975 Dec; 68(12):757-8. PubMed ID: 768989
    [No Abstract]   [Full Text] [Related]  

  • 49. Immunofluorescent studies in ocular cicatricial pemphigoid.
    Leonard JN; Hobday CM; Haffenden GP; Griffiths CE; Powles AV; Wright P; Fry L
    Br J Dermatol; 1988 Feb; 118(2):209-17. PubMed ID: 3280001
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Localized cicatricial pemphigoid (Brunsting-Perry syndrome).
    Gibson V; Tschen JA; Bean SF
    Cutis; 1986 Oct; 38(4):252-3. PubMed ID: 3536333
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Brunsting-Perry pemphigoid simulating basal cell carcinoma.
    Monihan JM; Nguyen TH; Guill MA
    J Am Acad Dermatol; 1989 Aug; 21(2 Pt 2):331-4. PubMed ID: 2666465
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antibodies against conjunctival basement membrane zone. Occurrence in cicatricial pemphigoid.
    Franklin RM; Fitzmorris CT
    Arch Ophthalmol; 1983 Oct; 101(10):1611-3. PubMed ID: 6354159
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Localized pemphigoid.
    Person JR; Rogers RS; Perry HO
    Br J Dermatol; 1976 Nov; 95(5):531-4. PubMed ID: 791337
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cicatricial pemphigoid.
    Ahmed AR; Kurgis BS; Rogers RS
    J Am Acad Dermatol; 1991 Jun; 24(6 Pt 1):987-1001. PubMed ID: 1869688
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Brunsting-Perry Pemphigoid as Differential Diagnosis of Nonmelanoma Skin Cancer.
    Eichhoff G
    Cureus; 2019 Aug; 11(8):e5400. PubMed ID: 31620323
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Successful Treatment of Brunsting-Perry Cicatricial Pemphigoid With Dupilumab.
    Raef HS; Elmariah SB
    J Drugs Dermatol; 2021 Oct; 20(10):1113-1115. PubMed ID: 34636516
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Reactivity of bullous pemphigoid antibodies to the basaloid cells of seborrheic keratosis by complement immunofluorescent staining (author's transl)].
    Harada T; Nishikawa T; Kurihara S; Hatano H
    Nihon Hifuka Gakkai Zasshi; 1978 Dec; 88(14):1019-20. PubMed ID: 368382
    [No Abstract]   [Full Text] [Related]  

  • 58. Immunofluorescent follow-up studies in patients with bullous dermatoses.
    Remy W; Bockendahl H; Stüttgen G
    Acta Derm Venereol; 1975; 55(2):117-20. PubMed ID: 48314
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bullous pemphigoid and ovarian cystadenocarcinoma. Immunologic studies.
    Dahl MV; Ristow S
    Arch Dermatol; 1978 Jun; 114(6):903-5. PubMed ID: 78684
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunofluorescent studies of ocular cicatricial pemphigoid.
    Furey N; West C; Andrews T; Paul PD; Bean SF
    Am J Ophthalmol; 1975 Nov; 80(5):825-31. PubMed ID: 1103627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.